FLT3 and leukemia: To exclude cell line-specific off-target biology interfering with the effects of kinase-inhibition, we tested leukemia-driving RTK mutations in an isogenic cellular background: Various human (mutant) FLT3 or KIT isoforms were stably transfected in the IL3-dependent murine pro B-cell line Ba/F3.